Henoch-Schönlein Purpura (IgA Vasculitis)
This clinical presentation is classic for Henoch-Schönlein purpura (HSP), also known as IgA vasculitis, and requires immediate hospital admission with corticosteroid therapy given the presence of gastrointestinal bleeding in addition to the characteristic purpuric rash and fever.
Diagnosis
The triad of bilateral lower extremity palpable purpura, fever, and GI bleeding in a 14-year-old male is pathognomonic for HSP 1, 2. This is the most common systemic vasculitis in children and adolescents, typically presenting with:
- Palpable purpura on lower extremities (100% of cases)
- Gastrointestinal involvement (50-75%): abdominal pain, GI bleeding, intussusception
- Arthralgia/arthritis (75%): typically knees and ankles
- Renal involvement (20-50%): hematuria, proteinuria, potential for crescentic glomerulonephritis
Key Diagnostic Points:
- Clinical diagnosis is sufficient when classic features are present 1
- Skin biopsy showing leukocytoclastic vasculitis with IgA deposition confirms diagnosis, but negative immunofluorescence does NOT exclude HSP 1
- The European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) classify positive IgA as supportive but not mandatory 1
Critical Initial Workup:
- Urinalysis with microscopy: Look for hematuria, proteinuria, RBC casts
- Renal function: BUN, creatinine (to detect nephritis early)
- Complete blood count: Assess for anemia from GI bleeding
- Stool guaiac/fecal occult blood: Confirm GI bleeding
- Blood pressure monitoring: Hypertension suggests renal involvement
Management Algorithm
Immediate Stabilization (First 24 Hours):
1. Assess Hemodynamic Stability:
- Calculate shock index (heart rate/systolic BP)
- If shock index >1 or hemodynamically unstable: Follow acute GI bleeding protocol 3
2. Initiate Corticosteroid Therapy:
- Intravenous methylprednisolone 1-2 mg/kg/day for severe GI bleeding 2, 4, 5
- This is critical: Corticosteroids have been shown to successfully treat massive GI hemorrhage in HSP, avoiding surgical intervention 5
- Transition to oral prednisone 1-2 mg/kg/day (max 60 mg) once stabilized, with gradual taper over 4-6 weeks 2
3. Hospital Admission:
- All patients with GI bleeding require admission 3
- Monitor for complications: intussusception, perforation, massive hemorrhage
Ongoing Management:
For Severe or Refractory Cases:
- IVIG (Intravenous Immunoglobulin): 2 g/kg as single dose if no improvement with corticosteroids 4
- Consider if persistent GI bleeding despite steroid therapy
- Has shown significant improvement in gastrointestinal, cutaneous, and articular symptoms 4
Renal Monitoring (Critical for Long-term Outcomes):
- Weekly urinalysis for first month, then monthly for 6 months
- If proteinuria develops or worsens: Consider renal biopsy
- Crescentic glomerulonephritis (most severe complication) may require cyclophosphamide 2
Common Pitfalls to Avoid:
- Adolescents have more severe disease than younger children—maintain high vigilance for complications 2
- Do NOT delay corticosteroids waiting for biopsy confirmation when clinical presentation is classic with GI bleeding 5
- Bleeding can occur from unusual sites: Terminal ileum near Meckel's diverticulum has been reported 2
- Cardiac complications are rare but serious: Monitor for arrhythmias (atrial fibrillation, ventricular tachycardia) 2
- Neurological complications can occur: Watch for proximal muscle weakness, tremors, clonus 2
- Disease can flare after initial improvement: Be prepared to reinitiate or increase corticosteroid dose 1
When to Escalate Therapy:
- Persistent GI bleeding despite IV methylprednisolone: Add IVIG 4
- Nephrotic-range proteinuria or rising creatinine: Urgent renal biopsy
- Crescentic glomerulonephritis on biopsy: IV cyclophosphamide 2
- Intussusception or perforation: Surgical consultation
Follow-up:
- Close monitoring for 6 months minimum
- Renal function and urinalysis at regular intervals
- Blood pressure checks
- Most patients recover fully, but renal involvement determines long-term prognosis
The combination of supportive care, aggressive corticosteroid therapy for GI bleeding, and vigilant monitoring for renal complications provides the best outcomes for morbidity and mortality in adolescent HSP patients 2, 4, 5.